Jamie Brannan - 18 Feb 2026 Form 4 Insider Report for Zoetis Inc. (ZTS)

Reporting relationship: Executive Vice President
Issuer ticker: ZTS
Reported as of: 18 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 20:51:45 UTC
Prior SEC filing: 10 Feb 2026
Next SEC filing: 23 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Jamie Brannan filed Form 4 for Zoetis Inc. (ZTS) on 19 Feb 2026.

Key facts

This page summarizes Jamie Brannan's Form 4 filing for Zoetis Inc. (ZTS).
2 reported transactions and 8 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 20:51.

Change

Previous filing in this sequence was filed on 10 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001952582 Primary reporting owner

Brannan Jamie

Relationship: Executive Vice President
Address: C/O ZOETIS INC., 10 SYLVAN WAY, PARSIPPANY
Signature: /s/ Brenda Santuccio, as Attorney-in-Fact
Signature date: 19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Award

Transaction value: $0
Shares: +5,399
Change %
Price: $0.000000
Shares after: 5,399
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,399
Exercise price
Footnotes: F1, F2, F3, F4

ZTS transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +21,361
Change %
Price: $0.000000
Shares after: 21,361
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 21,361
Exercise price: $129.13
Footnotes: F7, F8, F9

ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 3,614
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,614
Exercise price
Footnotes: F1, F2, F4, F5

ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 529
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 529
Exercise price
Footnotes: F1, F2, F4, F6

ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 13,877
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,877
Exercise price: $156.64
Footnotes: F7, F9, F10

ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 5,955
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,955
Exercise price: $196.14
Footnotes: F7, F9, F11

ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 4,103
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,103
Exercise price: $162.07
Footnotes: F7, F9, F12

ZTS holding Derivative

Stock Option

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 6,941
Date: 18 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,941
Exercise price
Footnotes: F9, F13, F14, F15

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 15 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F4

Not applicable.

Footnote F5

One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F6

One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F7

Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.

Footnote F8

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.

Footnote F9

Each option expires on the tenth anniversary of the date of grant.

Footnote F10

One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.

Footnote F11

One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.

Footnote F12

One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.

Footnote F13

Stock option (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.

Footnote F14

2,764 options granted February 13, 2018 at an exercise price of $73.24 per option; 1,465 options granted February 12, 2019 at an exercise price of $87.51 per option; 732 options granted February 11, 2020 at an exercise price of $144.03 per option; 869 options granted February 10, 2021 at an exercise price of $160.62; and 1,111 options granted February 8, 2022 at an exercise price of $201.30 per option.

Footnote F15

Each option vested on the third anniversary of the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .